Disease/Infection News

RSS

Breakthrough in tuberculosis treatment: TB-PRACTECAL trial reveals efficacy of new oral regimen

The TB-PRACTECAL clinical trial outcomes, which evaluated the efficacy and safety of oral bedaquiline.

20 Nov 2023

Avian influenza A H5N1 virus impacts wide range of wildlife in the U.S., study shows

Study highlights the spread of the highly pathogenic avian influenza A (H5N1) virus among non-domesticated animals in the U.S., revealing neurological symptoms as a key clinical presentation and expanding the range of species affected by this Eurasian lineage virus.

19 Nov 2023

Study finds high levels of enteric pathogens in children from Alabama's rural areas, highlights sanitation issues

The study reveals a significant presence of enteric pathogens in children from Alabama's Black Belt region, linking well water consumption to increased pathogen detection and underscoring the need for improved sanitation infrastructure.

19 Nov 2023

Pigeon virus causes fatal neurological disease in young leukemia patient

A case report details a fatal neurologic disease in an immunocompromised toddler caused by pigeon avian paramyxovirus, underscoring the effectiveness of metagenomic testing in diagnosing complex infectious diseases.

19 Nov 2023

Antibiotic use in EU rebounds to pre-pandemic levels, challenges 2030 reduction goal

The study reveals a post-pandemic rebound in antibiotic use across the EU/EEA, with 2022 levels returning to pre-COVID rates, highlighting the need for targeted interventions to meet antibiotic reduction goals by 2030.

19 Nov 2023

Antibiotic consumption in Europe rebounds to pre-pandemic levels

This year's European Antibiotic Awareness Day (EAAD) focuses on the targets outlined in the 2023 Council Recommendation to step up efforts in the European Union (EU) against antimicrobial resistance in a One Health approach.

17 Nov 2023

Study reveals significant post-COVID meningitis resurgence

A team of scientists from the Institut Pasteur has used the database of the National Reference Center for Meningococci to trace the evolution of invasive meningococcal disease cases in France between 2015 and 2022, revealing an unprecedented resurgence in the disease after the easing of control measures imposed during the COVID-19 epidemic.

17 Nov 2023

Simple soap solution could be a game-changer in the fight against malaria

Could the solution to the decades-long battle against malaria be as simple as soap? In a new study published in PLOS Neglected Tropical Diseases, scientists at The University of Texas at El Paso have made a compelling case for it.

17 Nov 2023

Green tea-silver nanoparticles: A promising weapon against superbugs

Once upon a time, people believed to be invincible against bacterial diseases, thanks to the antibiotics. Does this sound like a fairy tale? By all means! Nothing could be further from the truth.

17 Nov 2023

Immunogenicity of insect-specific Zika virus-vectorized vaccine candidates

The immunogenicity, safety, and effectiveness of ARPV/ZIKV a chimeric insect-specific flavivirus (ISFV)-Zika vaccine.

17 Nov 2023

Intensive pig farming linked to dangerous zoonotic pathogens, study warns

A recent study in PNAS reveals that the expansion of large-scale pig rearing has led to the emergence of novel, highly pathogenic Streptococcus suis strains, posing a potential zoonotic threat. The research highlights the critical need for monitoring and control strategies in the face of escalating livestock populations.

16 Nov 2023

Lasting heart concerns in kids post-MIS-C: Study urges ongoing cardiac checks

Researchers evaluated the long-term cardiovascular effects in children after treatment for MIS-C, a condition linked to COVID-19. They found that regardless of initial heart injury, most children displayed persistent cardiac abnormalities, underscoring the importance of ongoing cardiac monitoring post-recovery.

16 Nov 2023

Promising new cancer therapy appears to be extremely potent against tuberculosis

A promising new cancer therapy also appears extremely potent against one of the world's most devastating infectious diseases: tuberculosis (TB).

16 Nov 2023

Coffee and COVID: Study finds coffee inhibits SARS-CoV-2, offers new dietary defense strategy

Study discovers that coffee, especially its bioactive compounds like chlorogenic acids, can inhibit SARS-CoV-2 entry and reduce ACE2 and TMPRSS2 levels, indicating that coffee intake might be a potential dietary strategy for COVID-19 prevention.

16 Nov 2023

Diabetes linked to higher colorectal cancer risk in low-income African-Americans, study shows

JAMA Network Open study finds that diabetes increases colorectal cancer risk among low-income African-American individuals, with stronger associations observed in women, smokers, and those recently diagnosed, suggesting that glycemic control and colonoscopy screenings could mitigate risk.

16 Nov 2023

Photobiomodulation in Alzheimer's mouse model falls short in preventive impact

Study assesses the effectiveness of photobiomodulation (PBM) treatment in a mouse model of Alzheimer's disease and finds no significant impact on behavioral performance or neurodegeneration, suggesting the need for further research into PBM's therapeutic potential.

16 Nov 2023

New economic-pandemic model helps assess effectiveness of pandemic policies

Epidemic-Economic Model Provides Answers To Key Pandemic Policy Questions

16 Nov 2023

Grand Challenges Canada funding supports market introduction of dapivirine vaginal ring in Southern and East Africa

IPM South Africa NPC, an affiliate of the Population Council, has been issued a 15-month Transition to Scale Phase 2 award from Grand Challenges Canada to support the market introduction of the dapivirine vaginal ring (DapiRing) for women in Southern and East Africa.

16 Nov 2023

Researchers develop easy-to-calculate scales to predict COVID-19 severity

Factors associated with hospital admissions, ICU stays and mortality in patients who have had SARS-CoV-2 are identified, and clinical prediction rules are developed.

16 Nov 2023

Oral antibiotic taken once-daily for six months reduces risk of developing drug-resistant TB

Two landmark clinical trials reported today at the Union meeting showed that an oral antibiotic taken for six months once-daily substantially reduced the risk of developing drug-resistant TB.

16 Nov 2023

Disease/Infection News

Breakthrough in tuberculosis treatment: TB-PRACTECAL trial reveals efficacy of new oral regimen

Avian influenza A H5N1 virus impacts wide range of wildlife in the U.S., study shows

Study finds high levels of enteric pathogens in children from Alabama's rural areas, highlights sanitation issues

Pigeon virus causes fatal neurological disease in young leukemia patient

Antibiotic use in EU rebounds to pre-pandemic levels, challenges 2030 reduction goal

Antibiotic consumption in Europe rebounds to pre-pandemic levels

Study reveals significant post-COVID meningitis resurgence

Simple soap solution could be a game-changer in the fight against malaria

Green tea-silver nanoparticles: A promising weapon against superbugs

Immunogenicity of insect-specific Zika virus-vectorized vaccine candidates

Intensive pig farming linked to dangerous zoonotic pathogens, study warns

Lasting heart concerns in kids post-MIS-C: Study urges ongoing cardiac checks

Promising new cancer therapy appears to be extremely potent against tuberculosis

Coffee and COVID: Study finds coffee inhibits SARS-CoV-2, offers new dietary defense strategy

Diabetes linked to higher colorectal cancer risk in low-income African-Americans, study shows

Photobiomodulation in Alzheimer's mouse model falls short in preventive impact

New economic-pandemic model helps assess effectiveness of pandemic policies

Grand Challenges Canada funding supports market introduction of dapivirine vaginal ring in Southern and East Africa

Researchers develop easy-to-calculate scales to predict COVID-19 severity

Oral antibiotic taken once-daily for six months reduces risk of developing drug-resistant TB

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News